These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 12220549)

  • 41. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages.
    Williams L; Bradley L; Smith A; Foxwell B
    J Immunol; 2004 Jan; 172(1):567-76. PubMed ID: 14688368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of STATs in inflammation and inflammatory diseases.
    Pfitzner E; Kliem S; Baus D; Litterst CM
    Curr Pharm Des; 2004; 10(23):2839-50. PubMed ID: 15379672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells.
    Munthe LA; Corthay A; Os A; Zangani M; Bogen B
    J Immunol; 2005 Aug; 175(4):2391-400. PubMed ID: 16081810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticytokine therapy in autoimmune diseases.
    Nishimoto N; Kishimoto T; Yoshizaki K
    Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice.
    Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S
    J Clin Invest; 2004 Aug; 114(4):582-8. PubMed ID: 15314695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
    Lee Y; Mitsdoerffer M; Xiao S; Gu G; Sobel RA; Kuchroo VK
    J Clin Invest; 2015 Nov; 125(11):4011-20. PubMed ID: 26413871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells.
    Bruns HA; Schindler U; Kaplan MH
    J Immunol; 2003 Apr; 170(7):3478-87. PubMed ID: 12646608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
    Tanaka T; Narazaki M; Ogata A; Kishimoto T
    Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
    Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-10 and the interleukin-10 receptor.
    Moore KW; de Waal Malefyt R; Coffman RL; O'Garra A
    Annu Rev Immunol; 2001; 19():683-765. PubMed ID: 11244051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis.
    Keul R; Heinrich PC; Müller-newen G; Muller K; Woo P
    Cytokine; 1998 Sep; 10(9):729-34. PubMed ID: 9770335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
    Hirano T
    Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.
    Nakajima K; Yamanaka Y; Nakae K; Kojima H; Ichiba M; Kiuchi N; Kitaoka T; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Jul; 15(14):3651-8. PubMed ID: 8670868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
    Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
    Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physiological effects of modulating the interleukin-6 axis.
    Schett G
    Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii43-ii50. PubMed ID: 29982781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway.
    Eugster HP; Frei K; Winkler F; Koedel U; Pfister W; Lassmann H; Fontana A
    Eur J Immunol; 2001 Aug; 31(8):2302-12. PubMed ID: 11477542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FGF2 cooperates with IL-17 to promote autoimmune inflammation.
    Shao X; Chen S; Yang D; Cao M; Yao Y; Wu Z; Li N; Shen N; Li X; Song X; Qian Y
    Sci Rep; 2017 Aug; 7(1):7024. PubMed ID: 28765647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.